Floatz logo

Glutamine

Sickle Cell Anemia

Ain Shams UniversitySmall moleculePhase 4 / ApprovedActive
BBB
72/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
60/ 100
Competitive Position
89/ 100

Competitive context

134 Active assets in the Sickle Cell Anemia cohort.

Asset / SponsorPhaseRating
Hydroxyurea
St. Jude Children's Research Hospital
Phase 4BB
Crizanlizumab
Novartis Pharmaceuticals
Phase 4BB
MAGNESIUM METALLICUM
Medical College of Wisconsin
Phase 3BB
FILGRASTIM
St. Jude Children's Research Hospital
Phase 4BB
NEPENTHE
Oman Medical Speciality Board
Phase 4BB

View all 50 →

Same molecule, other indications

Glutamine is also rated in:

Duchenne muscular dystrophyDormant
BB
Indicative ·
68 / 100
View asset →
PharmacokineticsDormant
B
Indicative ·
62 / 100
View asset →
peripheral neuropathyDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →